Anticoagulant chitosan-kappa-carrageenan composite hydrogel sorbent for simultaneous endotoxin and bacteria cleansing in septic blood

Yupei Li,Jiameng Li,Zhenqiang Shi,Yilin Wang,Xin Song,Liya Wang,Mei Han,Heyue Du,Chao He,Weifeng Zhao,Baihai Su,Changsheng Zhao
DOI: https://doi.org/10.1016/j.carbpol.2020.116470
IF: 10.723
2020-09-01
Carbohydrate Polymers
Abstract:<p>Here, we describe a green approach to fabricate genipin crosslinked chitosan-kappa-carrageenan composite hydrogels (C-K hydrogels) aiming at reducing endotoxin level and bacteria burden in septic blood synchronously. The chemical compositions and morphologies of the developed C-K hydrogels were characterized by Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy and scanning electron microscopy. The C-K hydrogels significantly inhibited adverse blood-material interactions such as hemolysis, complement activation, platelet activation and contact activation, and exhibited better anticoagulant properties than raw chitosan hydrogels. Most importantly, the optimized C<sub>2</sub>-K<sub>1</sub> hydrogels were competent to eliminate 63.3% of endotoxin in septic blood with a maximum adsorption capacity of 95.0 EU/g during a 3-h simulative hemoperfusion procedure. Bacteria cleansing experiments further demonstrated that the optimized C<sub>2</sub>-K<sub>1</sub> hydrogels effectively decreased 46.0% of <em>E. coli</em> and 68.7% of <em>S. aureus</em> load, respectively. It is believed that the C-K hydrogels are promising hemoperfusion sorbents to treat severe septic patients.</p>
polymer science,chemistry, organic, applied
What problem does this paper attempt to address?
The paper aims to address a critical issue in the treatment of sepsis, specifically how to effectively remove endotoxins and bacterial load from the blood of sepsis patients. Specifically, the study developed a novel blood dialysis adsorbent based on chitosan and kappa-carrageenan composite hydrogels (C-K hydrogels). This adsorbent can significantly reduce endotoxin levels and decrease the number of Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) during in vitro simulated blood dialysis. Through this method, the researchers propose a new strategy to combat sepsis by maximizing the therapeutic effect of extracorporeal blood purification through the removal of endotoxins and bacteria.